Ballicules › Drugs › Ursodiol
What it is Hydrophilic bile acid that displaces toxic bile acids; primary biliary cholangitis and cholesterol gallstones.
Why this one It is the only treatment that improves transplant-free survival in primary biliary cholangitis.
What limits it It dissolves only small, non-calcified cholesterol stones, and slowly. Diarrhea; stones recur when it is stopped.
FDA-approved for
primary biliary cholangitis (1997) gallstone dissolution
Off-label
intrahepatic cholestasis of pregnancy
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Radiolucent gallbladder stone dissolution Adults 8–10 mg/kg/day in 2–3 divided doses 8–10 mg/kg/day 10 mg/kg/day
Gallstone prevention during rapid weight loss Adults 300 mg BID 600 mg/day 600 mg/day
Renal Undefined
Hepatic Undefined
Instructions Obtain gallbladder ultrasound at 6-month intervals during the first year to monitor dissolution If stones appear dissolved, confirm with repeat ultrasound in 1–3 months If no partial dissolution by 12 months, success is unlikely
Contraindications Calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones (will not dissolve) Compelling reasons for cholecystectomy: unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula
Cautions Ineffective for calcified cholesterol, radiopaque, or bile pigment stones
Adverse reactions Diarrhea Abdominal pain Nausea, vomiting, dyspepsia, constipation Headache, dizziness Back pain, arthralgia Upper respiratory tract infection
Pregnancy Animal studies show no fetal harm at therapeutic multiples; not recommended during pregnancy
Lactation Undefined
Principal risk Diarrhea
Cost, est. cash $5–$150/month
Generic entry 2000
Classes and tags
Clinical profile
Therapeutic safety burden 1 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Mechanism of action: Ursodiol ballicule
Open Ursodiol in the interactive console ↗
Memory aids: mascots and interaction avatars
“Urso Active against gallstones”
Open Ursodiol in the interactive console ↗